abstract |
The invention relates to compounds of general formula (1), wherein L, Q<SUB>1</SUB>, Q<SUB>2</SUB>, X, Y, R<SUP>a</SUP>, R<SUP>b</SUP>, R<SUP>c</SUP>, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, and R<SUP>4</SUP> are defined as indicated in claim 1. Said compounds are suitable for the treatment of diseases characterized by excessive or anomalous cell proliferation. Also disclosed is the use of said compounds for producing a medicament having said properties. |